Option chain shows key data for Ascentage Pharma Group's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Ascentage Pharma Group.

Ascentage Pharma Group (OTC:ASPHF) Stock, Option Chain

Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis or programmed cell death. The Group has one reportable operating segment, which is discovering, developing, and commercializing therapies to address medical needs in hematological malignancies. The company's geographical segments include the United States and Mainland China.

Asia

Biotech

News

Markets

General

ASPHF

Key Takeaways:


	Under the partnership, Japan’s Takeda International gets an option to market Ascentage’s promising leukemia drug outside of China
	Without the capital infusion from Takeda, Ascentage was facing a liquidity crisis with just a year’s worth of cash


By Molly Wen

Ascentage Pharma Soars On Deal With Cancer Drug Competitor

ASCENTAGE PHARMA GROUP by ASCENTAGE PHARMA GROUP

Comments

Ascentage Pharma Group

Ascentage Pharma Group (ASPHF) Options

No option chain data available. Please try again later

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell